Detection of viral pathogens in high grade gliomas from unmapped next-generation sequencing data

Experimental and Molecular Pathology

Volumn 96, Issue 3, 2014, Pages 310-315

  Cimino, Patrick J ^a   Zhao, Guoyan ^a   Wang, David ^a   Sehn, Jennifer K ^a   Lewis, James S ^a   Duncavage, Eric J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glioblastoma; Gliosarcoma; Merkel cell; Next generation sequencing; Squamous cell carcinoma; Virus

Indexed keywords

GLIOBLASTOMA; GLIOSARCOMA; MERKEL CELL; NEXT GENERATION SEQUENCING; SQUAMOUS CELL CARCINOMA; VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BURKITT LYMPHOMA; CARCINOMA, SQUAMOUS CELL; CHILD; DNA COPY NUMBER VARIATIONS; FEMALE; GLIOMA; HERPESVIRUS 4, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; RNA, VIRAL; ROSEOLOVIRUS; SEQUENCE ANALYSIS, DNA;

EID: 84898647497     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.03.010     Document Type: Article

References (56)

1. Almohmeed Y.H., et al. Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis. PLoS One 2013, 8:e61110.
2. Altschul S.F., et al. Basic local alignment search tool. J. Mol. Biol. 1990, 215:403-410.
3. Balfour H.H., et al. Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. J. Infect. Dis. 2013, 208:1286-1293.
4. Chernock R.D., et al. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol. 2009, 3:186-194.
5. Chiu C.Y. Viral pathogen discovery. Curr. Opin. Microbiol. 2013, 16:468-478.
6. Cimino P.J., et al. Detection of Merkel cell polyomavirus in chronic lymphocytic leukemia T-cells. Exp. Mol. Pathol. 2013, 94:40-44.
7. Cimino P.J., et al. Retinoblastoma gene mutations detected by whole exome sequencing of Merkel cell carcinoma. Mod. Pathol. 2014, (E-pub ahead of print, January 10).
8. Cobbs C.S., et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002, 62:3347-3350.
9. Cottrell C.E., et al. Validation of a next-generation sequencing assay for clinical molecular oncology. J. Mol. Diagn. 2014, 16:89-105.
10. Daly G.M., et al. A viral discovery methodology for clinical biopsy samples utilising massively parallel next generation sequencing. PLoS One 2011, 6:e28879.
11. DeBoever C., et al. Whole transcriptome sequencing enables discovery and analysis of viruses in archived primary central nervous system lymphomas. PLoS One 2013, 8:e73956.
12. Disanto G., et al. Epstein-Barr virus, latitude and multiple sclerosis. Mult. Scler. 2013, 19:362-365.
13. Dowd J.B., et al. Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010. PLoS One 2013, 8:e64921.
14. Duncavage E.J., et al. Hybrid capture and next-generation sequencing identify viral integration sites from formalin-fixed, paraffin-embedded tissue. J. Mol. Diagn. 2011, 13:325-333.
15. Dziurzynski K., et al. Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol. 2012, 14:246-255.
16. Evens A.M., et al. Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era. Am. J. Transplant. 2013, 13:1512-1522.
17. Feng H., et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319:1096-1100.
18. Fu L., et al. CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics 2012, 28:3150-3152.
19. Green P. Phrap. phrap version 1.090518 2009.
20. Ho K.L., et al. Cytomegalovirus infection of cerebral astrocytoma in an AIDS patient. Clin. Neuropathol. 1991, 10:127-133.
21. Hon G.M., et al. Assessment of Epstein-Barr virus in blood from patients with multiple sclerosis. Metab. Brain Dis. 2012, 27:311-318.
22. Khoury J.D., et al. Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J. Virol. 2013, 87:8916-8926.
23. Kitai R., et al. Epstein-Barr virus-associated primary central nervous system lymphoma in the Japanese population. Neurol. Med. Chir. (Tokyo) 2010, 50:114-118.
24. Kofman A., et al. The roles of viruses in brain tumor initiation and oncomodulation. J. Neurooncol. 2011, 105:451-466.
25. Lau S.K., et al. Lack of association of cytomegalovirus with human brain tumors. Mod. Pathol. 2005, 18:838-843.
26. Lay M.L., et al. Epstein-Barr virus genotypes and strains in central nervous system demyelinating disease and Epstein-Barr virus-related illnesses in Australia. Intervirology 2012, 55:372-379.
27. Lehrer S. Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor. Med. Hypotheses 2012, 78:657-658.
28. Lehrer S., et al. No circulating cytomegalovirus in five patients with glioblastoma multiforme. Anticancer Res. 2011, 31:959-960.
29. Lehrer S., et al. No consistent relationship of glioblastoma incidence and cytomegalovirus seropositivity in whites, blacks, and Hispanics. Anticancer Res. 2012, 32:1113-1115.
30. Levine H., et al. Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults. Ann. Epidemiol. 2012, 22:783-788.
31. Li R., et al. SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics 2009, 25:1966-1967.
32. Lucas K.G., et al. The detection of CMV pp 65 and IE1 in glioblastoma multiforme. J. Neurooncol. 2011, 103:231-238.
33. Lucas R.M., et al. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination. Neurology 2011, 77:371-379.
34. Martelius T., et al. Clinical characteristics of patients with Epstein Barr virus in cerebrospinal fluid. BMC Infect. Dis. 2011, 11:281.
35. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 2011, 17:2.
36. Murata T., Tsurumi T. Switching of EBV cycles between latent and lytic states. Rev. Med. Virol. 2013, (E-pub ahead of print, December 11).
37. Naeem R., et al. READSCAN: a fast and scalable pathogen discovery program with accurate genome relative abundance estimation. Bioinformatics 2013, 29:391-392.
38. Price R.L., et al. Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations. Cancer Res. 2013, 73:3441-3450.
39. Prins R.M., et al. Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. N. Engl. J. Med. 2008, 359:539-541.
40. Saglam A., et al. Epstein-Barr virus frequency in primary central nervous system lymphomas in Turkey. APMIS 2013, 121:232-238.
41. Sampson J.H., Mitchell D.A. Is cytomegalovirus a therapeutic target in glioblastoma?. Clin. Cancer Res. 2011, 17:4619-4621.
42. Scheurer M.E., et al. Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol. 2008, 116:79-86.
43. Schmieder R., Edwards R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 2011, 27:863-864.
44. Soderberg-Naucler C., et al. Survival in patients with glioblastoma receiving valganciclovir. N. Engl. J. Med. 2013, 369:985-986.
45. Swaminathan S. Post-transcriptional gene regulation by gamma herpes viruses. J. Cell. Biochem. 2005, 95:698-711.
46. Takacs M., et al. Epigenetic regulation of latent Epstein-Barr virus promoters. Biochim. Biophys. Acta 2010, 1799:228-235.
47. Takada K., Nanbo A. The role of EBERs in oncogenesis. Semin. Cancer Biol. 2001, 11:461-467.
48. Tao Q., Robertson K.D. Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection. Clin. Immunol. 2003, 109:53-63.
49. Teman C.J., et al. Merkel cell polyomavirus (MCPyV) in chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk. Res. 2011, 35:689-692.
50. Thompson M.P., Kurzrock R. Epstein-Barr virus and cancer. Clin. Cancer Res. 2004, 10:803-821.
51. Ukpo O.C., et al. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am. J. Surg. Pathol. 2011, 35:1343-1350.
52. Weller M., et al. The legend of cytomegalovirus and glioblastoma lives on. Neuro Oncol. 2014, 16:166.
53. Wick W., Platten M. CMV infection and glioma, a highly controversial concept struggling in the clinical arena. Neuro Oncol. 2014, 16:332-333.
54. Yamashita Y., et al. Lack of presence of the human cytomegalovirus in human glioblastoma. Mod. Pathol. 2013, (E-pub ahead of print, December 13).
55. Yu G., et al. Discovery of a novel polyomavirus in acute diarrheal samples from children. PLoS One 2012, 7:e49449.
56. Zhao G., et al. Identification of novel viruses using VirusHunter - an automated data analysis pipeline. PLoS One 2013, 8:e78470.